Sun Pharmaceutical Industries Ltd. closed 4.84% short of its 52-week high of 1,850.95 rupees, which the company achieved on May 2nd.
Gujarat is launching a major push into AI and the digital economy with a dedicated IT-AI cluster near GIFT City and the ...
The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug ...
Halvio Capital returned 5.62 percent this quarter while exploring international value opportunities. View our latest partner ...
Across FY26–28, Jefferies forecasts double-digit revenue growth for the sector, led by Biocon (14%), boosted by upcoming ...
They have also shared an outlook on pharma, telecom, internet platforms, banking, metals and consumer sectors, alongside ...
This Cervical Cancer Awareness Month, Teal Health kicks off a joint effort with industry leading women's health and lifestyle ...
Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative therapies, including OPZELURA®, povorcitinib, ILUMYA®, ODOMZO®, REMICADE®, and ...
Natco’s escalates the legal battle over semaglutide, one of the world’s most valuable and closely contested pharmaceutical ...
India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...
Indian drugmakers, known for their chemistry and prowess in making generics—cheaper copies of innovative drugs—for the world, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback